NASDAQ : DMAC

DiaMedica Therapeutics Inc.

$7.3 USD

$0.17 (2.38%)

Volume
199.16K
Average Volume
199.28K
Market Capitalization
$393.35M
P/E Ratio
-10.28
Dividend Yield
0.00%
Price Target
$8.00
Year High
$10.42
Year Low
$3.88
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$9.11
3333332"{? p/.m7yd f,0=

Annual earnings financials

DMAC financial data with annual/quarterly toggle

DMAC GAAP EPS - Annual & Quarterly

DMAC Sales Revenue - Annual & Quarterly

DMAC Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

DMAC Estimated and Actual Revenue by Quarter
DMAC Estimated and Actual EPS by Quarter
DMAC Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 0 - - - - - -
2027-09-30 0 - - - - - -
2027-06-30 0 - - - - - -
2027-03-31 0 - - - - - -
2026-12-31 1 - - - - - -
2026-09-30 1 - - - - - -
DMAC Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 0 -10.52M -10.52M -10.52M - - -
2027-09-30 0 -10.52M -10.52M -10.52M - - -
2027-06-30 0 -10.52M -10.52M -10.52M - - -
2027-03-31 0 -10.52M -10.52M -10.52M - - -
2026-12-31 1 -12.14M -12.14M -12.14M - - -
2026-09-30 1 -11.48M -11.48M -11.48M - - -
DMAC Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 0 - - - 1 -0.1955 -0.1955 -0.1955
2027-09-30 0 - - - 1 -0.1955 -0.1955 -0.1955
2027-06-30 0 - - - 1 -0.1955 -0.1955 -0.1955
2027-03-31 0 - - - 1 -0.1955 -0.1955 -0.1955
2026-12-31 1 13.5M 13.5M 13.5M 1 -0.22575 -0.22575 -0.22575
2026-09-30 1 13.5M 13.5M 13.5M 2 -0.21342 -0.21342 -0.21342